NCT06324851View on ClinicalTrials.gov

The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

March 1, 2024

Conditions
Endometrial PolypEndometrial Diseases
Interventions
DRUG

Drospirenone / Estetrol

Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Drospirenone/Estetrol at any time of the menstrual cycle

DRUG

Nomegestrol Acetate / Estradiol

Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Nomegestrol Acetate/Estradiol at any time of the menstrual cycle

DRUG

Ethinylestradiol / Dienogest

Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest at any time of the menstrual cycle

Trial Locations (2)

90123

Andrea Etrusco, Palermo

00161

Marco Monti, Rome

All Listed Sponsors
collaborator

University of Roma La Sapienza

OTHER

lead

University of Palermo

OTHER